in #CASE you missed it… AstraZeneca: COVID Vaccine
AstraZeneca: Expect Late Stage COVID Vaccine Trial Results At Year’s End -
The British pharmaceutical giant said today it anticipates having results from late-stage trials later this year.
AstraZeneca said it will submit data readouts to regulators and publish in peer-reviewed scientific journals.
AstraZeneca is working with the University of Oxford to develop a vaccine. there are 200 vaccines being worked on, but this is seen as the frontrunner.